Skip to main content

Empowering medical students to manage polypharmacy

Polypharmacy, commonly defined as the concurrent use of five or more medications, is a growing challenge in modern healthcare, especially among older adults with multiple long-term conditions. While advances in medicine have improved disease management, they have also led to an unintended consequence: a rising medication burden that can harm patient well-being. 

Our recent study published in Clinical Practice explores how reframing polypharmacy as a chronic condition can empower future doctors to manage it more effectively. For example, polypharmacy substantially increases the risk of adverse drug reactions (ADRs). This underscores the urgent need for a shift in how we approach medication management. 

Traditional medical education focuses on treating individual diseases, often leading to prescribing cascades where one drug’s side effect triggers another prescription. This cycle complicates care and worsens outcomes. We designed a three-phase educational intervention for final-year medical students. The program included interactive workshops that introduced polypharmacy risks, diagnostic tools, and case-based learning using electronic health records (EHRs) and clinical decision-support systems (CDSS). Simulated patient consultations and medication reviews with pharmacists to identify drug interactions and propose deprescribing strategies. Finally, debriefing sessions and reflective diaries help to integrate insights into future practice.

The intervention yielded significant improvements. Students’ confidence in recognizing polypharmacy as a primary diagnostic issue jumped from 32% to 86% and their knowledge of diagnostic tools increased from 3.1 to 4.7 out of 5. Standardized patient satisfaction scores also rose from 3.5 to 4.8, reflecting better communication and patient-centred care. Reflective diaries revealed a shift toward holistic thinking, with students better equipped to identify drug-induced symptoms and collaborate with multidisciplinary teams.

By teaching polypharmacy as a chronic condition, this model equips medical students with the skills to break prescribing cascades, enhance patient safety, improve quality of life for patients and reduce healthcare costs. The study’s small sample size limits generalisability but it offers a promising blueprint for updating medical curricula. Future research should explore the long-term impact of such new educational models on patient outcomes and clinical decision-making. Integrating patient feedback and real-world testimonials could further enrich this approach. 

As healthcare evolves, empowering clinicians to manage medication burden proactively is essential for improving quality of life. This innovative training is a step toward a more holistic, patient-centred approach in medicine. 

Citation: Conte, A.; Sedghi, A.; Majeed, A.; Jerjes, W. Reframing Polypharmacy: Empowering Medical Students to Manage Medication Burden as a Chronic Condition. Clin. Pract. 2025, 15, 142. https://doi.org/10.3390/clinpract15080142

Comments

Popular posts from this blog

What is the difference between primordial prevention and primary prevention?

Primordial prevention and primary prevention are both crucial strategies for promoting health, but they operate at different levels. Primordial prevention aims to address the root causes of health problems and improve the wider determinants of health. It focuses on preventing the emergence of risk factors in the first place by tackling the underlying social, economic, and environmental determinants of health. This involves broad, population-wide interventions such as: Policies that promote healthy food choices: Think about initiatives like taxing sugary drinks to discourage unhealthy consumption, or providing subsidies for fruits and vegetables to make them more accessible. Urban planning that prioritises well-being: This could include creating walkable neighborhoods with safe cycling routes, ensuring access to green spaces for recreation and relaxation, and designing communities that foster social connections. Social programs that address inequality: Initiatives aimed at reducing pov...

UK Covid-19 Inquiry - The Importance of a Strong Primary Healthcare System

In my witness statement for Module 10 of the UK Covid-19 Inquiry, I discuss the pandemic's impact through from the perspectives of  primary care and public health, drawing on my extensive experience as a senior academic at Imperial College London and as a practising GP and NHS Public Health Specialist.  I emphasise that the pandemic disproportionately affected people who were clinically vulnerable, the disabled, ethnic minority communities and those living in deprived areas. The pandemic highlighted how structural inequalities, multigenerational housing, and employment in high-risk frontline roles exacerbated health disparities.  My statement also critiques the weakening of public health infrastructure - particularly for the control of infectious diseases - and the lack of integrated health data systems to identify at-risk groups such as the clinically vulnerable. I also advocated for a more robust preventive healthcare model that prioritises community-based primary care ...

Protecting Young People from Meningococcal B Disease: The NHS Targeted Vaccination Programme

Meningococcal group B (MenB) infections are rare but can have devastating consequences. The decision to offer a targeted two-dose vaccination programme to Year 13 students and young people entering university or residential further education reflects concerns about recent outbreaks of meningococcal disease and the higher risk of transmission when large numbers of young adults mix closely for the first time in shared accommodation. The MenB vaccine has a well-established safety record, and evidence from the UK infant immunisation programme has shown substantial reductions in disease among vaccinated children. A targeted programme for those entering higher-risk settings is therefore a reasonable precautionary measure while further evidence is gathered on whether the recent increase in clusters represents a temporary fluctuation in disease patterns or a more sustained change in the epidemiology of MenB infection. The success of the programme will depend on achieving high uptake and ensuri...